Product Information
LEVOFLOXACIN 250 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1086 per EA under NDC 72578009818. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on Sep 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578009818
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA077652FDA Approved
9/7/2012
TE Code
AB
On Market Since
1/10/2022
Price Statistics
The NADAC for LEVOFLOXACIN 250 MG TABLET has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 36.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1086 per EA |
|---|---|
| All-time high | $0.1701 (Aug 10, 2022) |
| All-time low | $0.0920 (Nov 20, 2024) |
| 52-week high | $0.1164 |
| 52-week low | $0.1027 |
| Median price | $0.1268 |
| Average price | $0.1279 |
| Largest weekly change | -38.1% (Nov 20, 2024) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOFLOXACIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOFLOXACIN 250 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.1086 per EA (NDC 72578009818), effective Sep 30, 2026.
How has the price of LEVOFLOXACIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOFLOXACIN 250 MG TABLET has declined 36.1%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for LEVOFLOXACIN 250 MG TABLET?
Since Aug 10, 2022, the NADAC for LEVOFLOXACIN 250 MG TABLET has ranged from a low of $0.0920 (Nov 20, 2024) to a high of $0.1701 (Aug 10, 2022), with a median of $0.1268 per EA.
Are there cheaper alternatives to LEVOFLOXACIN 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LEVOFLOXACIN 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVOFLOXACIN 250 MG TABLET?
LEVOFLOXACIN 250 MG TABLET (NDC 72578009818) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.